@ShahidNShah
Grand Plans for Potential COVID-19 Vaccine Production
UK-based drugmaker AstraZeneca expands its plans with regard to the COVID-19 vaccine, doubling its manufacturing capacity to 2 billion doses and securing deals with a number of partners.
Continue reading at healthmanagement.org
Make faster decisions with community advice
Next Article
-
CVS study: Broad-panel sequencing lowers long-term cancer care costs
Broad-panel genomic sequencing may bring down the overall cost of care for cancer patients, a recent CVS study shows.
Posted Jun 9, 2020cancer